GlaxoSmithKline Investor Relations team
GLAXOSMITHKLINE INVESTOR RELATIONS TEAM We are pleased to welcome Philip Thomson to the GlaxoSmithKline Investor Relations team based in the UK with effect from 18th March 2002. Phil has been appointed to the position of Director, Investor Relations, GSK plc reporting to Duncan Learmouth, Vice President, Investor Relations. Phil joined GlaxoWellcome in 1996, as a commercial trainee. In 1999, he was appointed as UK Communications Manager and then spent two years in Corporate Media where he was appointed as Director in 2001. We would also like to take this opportunity to inform you of GlaxoSmithKline's office move. As of 2nd April 2002 we will be based at: 980 Great West Road, Brentford, Middlesex TW8 9GS Our telephone and fax numbers, and email addresses will change from 2nd April 2002. Please see attached for details. Duncan Learmouth Vice President, Investor Relations From 2nd April 2002 Investor Relations Department GlaxoSmithKline House 980 Great West Road Brentford Middlesex TW8 9GS UK Duncan Learmouth, Vice President, Investor Relations Tel: +44 (0)20 8047 5540 Mobile: +44 (0)7798 570737 e-mail: duncan.learmouth@gsk.com Anita Kidgell Vice President, Investor Relations Tel: +44 (0)20 8047 5542 Mobile: +44 (0)7802 608232 e-mail: anita.e.kidgell@gsk.com Phil Thomson, Director, Investor Relations Tel: +44 (0)20 8047 5543 Mobile: + 44 (0)7771 673860 e-mail: philip.c.thomson@gsk.com Jackie Francis, IR Administrator Tel: +44 (0)20 8047 5557 e-mail: jackie.a.francis@gsk.com Andrea Clark, Administrative Assistant Tel: +44 (0)20 8047 5558 e-mail: andrea.j.clark@gsk.com Fax number for all of the above: +44 020 8047 7807 ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2002/03/08/20020308BIT00410/wkr0001.doc http://www.waymaker.net/bitonline/2002/03/08/20020308BIT00410/wkr0002.pdf